Ultrasound for Evaluation of Percutaneous G-tube Position
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Apr 9, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of ultrasound imaging to check the position of a gastrostomy tube (GT) in children who recently had their GT replaced. The researchers want to find out if ultrasound can provide just as accurate information as a traditional method called fluoroscopy, and if it takes less time to perform. By comparing both methods, the trial aims to improve how we monitor GT placement, which is important for patient safety and comfort.
To participate, children aged 0 to 17 who have a dislodged GT and meet certain conditions may be eligible. These conditions include having had their GT placed less than 90 days ago, experiencing a traumatic dislodgement, or needing a recent stoma dilation. Participants will first undergo an ultrasound exam to assess their GT position, followed by the standard fluoroscopic imaging. This study is currently looking for participants, and it’s important to note that children who are acutely ill or over 18 years old cannot join. Overall, this trial could help determine a quicker and effective way to ensure gastrostomy tubes are positioned correctly, enhancing care for pediatric patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- An individual who presents with a dislodged GT and meets one of the following minor criteria:
- • Surgical GT placement less than 90 days from presentation
- • Traumatic GT dislodgement/removal
- • Recent stoma dilation
- • Clinician uncertainty about position of GT placement
- Exclusion Criteria:
- • An individual \>18 years of age
- • Acutely ill patients defined as hemodynamically unstable defined as any child who has abnormal vital signs or disruption of vital functions (i.e. airway, breathing, circulation, mental function). Vital signs are based on patient age. Initial assessment of clinical patient stability will be provided by the ordering/referring provider.
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
William Pryor, MD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported